Behavioural Health FDA Approval Medicine Production 
pharmaphorum
OCTOBER 2, 2020
Like its earlier digital therapies for alcohol misuse and depression , Modia’s earlier-than-expected rollout stems from legislation that has made it possible to secure reimbursement for certain digital products for psychiatric disorders during the COVID-19 pandemic.
pharmaphorum
MARCH 21, 2022
Alongside those organisations sat well-known companies and agencies, such as the National Institute of Health (NIH), Johnson & Johnson, HDMS of CVS Health, Microsoft, Meta, and HP, determined to be part of the fast-growing immersive reality industry. In 2021, the behavioural health company and Sumitomo Dainippon Pharma Co.
Expert insights. Personalized for you.
98 
Let's personalize your content